Concepedia

Prabal K. Chatterjee

PK

53

Publications

4.3K

Citations

35

H-Index

1994

Active since

Affiliations

William Harvey Research Institute(Current)

University of Messina

Queen Mary University of London

University of Aberdeen

University of Brighton

Prabal K. Chatterjee is an author at William Harvey Research Institute specializing in medicine, pharmacology, and oxidative stress.

Top concepts

MedicinePharmacologyOxidative StressNephrologyVascular BiologyPhysiologyInflammationUrologyBiochemistryRenal Pharmacology

Publications per year

1994–2010

53

Publications

53

Ligands of the peroxisome proliferator‐activated receptors (PPAR‐γ and PPAR‐α) reduce myocardial infarct size

Nicole S. Wayman, Yoshiyuki Hattori, Michelle C. McDonald et al. · The FASEB Journal · 2002 · 359 citations

Heart Failure, Cardiovascular Disease, Biochemistry +14

Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat

Prabal K. Chatterjee, Salvatore Cuzzocrea, Paul A. Brown et al. · Kidney International · 2000 · 351 citations · Full text

Oxysterol, Medicine, Lipid Peroxidation +8

Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury

Prabal K. Chatterjee, Nimesh S. A. Patel, Espen Ø. Kvale et al. · Kidney International · 2002 · 239 citations · Full text

Inflammation, Reactive Nitrogen Specie, Medicine +11

RETRACTED: Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-γ, reduces acute inflammation

Salvatore Cuzzocrea, Maria Barbara Pisano, Laura Dugo et al. · European Journal of Pharmacology · 2003 · 216 citations

Inflammation, Anti-inflammatory, Medicine +8

RETRACTED: Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation

Salvatore Cuzzocrea, Prabal K. Chatterjee, Emanuela Mazzon et al. · British Journal of Pharmacology · 2002 · 210 citations · Full text

Rows per page

1–5 of 53